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Abstract
Greater psychosocial risk in childhood and adolescence predicts poorer cardiometabolic outcomes in adulthood. We assessed whether the
timing of psychosocial risk from infancy through adolescence predicts cardiometabolic outcomes in young adulthood. Young adults and
their mothers participated in a longitudinal study beginning in infancy in Santiago, Chile (N = 1040). At infancy, 5 years, 10 years, and
adolescence, mothers reported on depressive symptoms, stressful experiences, support for child development in the home, father absence,
parental education, and socioeconomic status (SES) to create a psychosocial risk composite at each time point. Young adults (52.1% female;
21–27 years) provided fasting serum samples and participated in anthropometric and blood pressure (BP) assessments, including a dualenergy X-ray absorptiometry (DXA) scan for measuring body fat. Greater infant psychosocial risk was associated with a greater young adult
metabolic syndrome score (β = 0.07, 95% confidence intervals (CI): 0.01 to 0.13, p = 0.02), a higher body mass index and waist circumference composite (β = 0.08, 95% CI: 0.03 to 0.13, p = 0.002), and a higher body fat (DXA) composite (β = 0.07, 95% CI: 0.01 to 0.12, p = 0.02).
No psychosocial risk measure from any time point was associated with BP. Infant psychosocial risk predicted cardiometabolic outcomes in
young adulthood better than psychosocial risk at 5 years, 10 years, or adolescence, mean of psychosocial risk from infancy through adolescence, and maximum of psychosocial risk at any one time. Consistent with the Developmental Origins of Health and Disease model, findings suggest that infancy is a sensitive period for psychosocial risk leading to poorer cardiometabolic outcomes in young adulthood.
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Psychosocial stressors and low socioeconomic status (SES) during
childhood and adolescence are associated with a greater risk of
cardiovascular disease (CVD) and metabolic disorders in adulthood, with more severe and chronic stressors associated with
increasing risk for adult chronic diseases (Dong et al., 2004;
Fuller-Thomson, Brennenstuhl, & Frank, 2010; Gilbert et al.,
2015; Kittleson et al., 2006). The latest consensus of the
American Heart Association (AHA) identifies adverse environments during childhood and adolescence as important determinants of obesity, Type 2 diabetes, and coronary heart disease in
the American population, especially in socially vulnerable groups
(Suglia et al., 2018). Many studies that examine associations
between childhood and adolescent stress and adult cardiometabolic diseases measure retrospective reports of early life psychosocial stress and adult cardiometabolic risk. This approach is
problematic as adult reports of stress during childhood may be
inaccurate due to memory limitations or biased by current levels
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of stress, psychopathology, health problems, or personality
dimensions such as neuroticism (Baldwin, Reuben, Newbury, &
Danese, 2019). Retrospective research is particularly problematic
in determining whether there are sensitive periods of development during which psychosocial stress is more strongly associated
with adult cardiometabolic risk. Few studies have assessed
psychosocial stress prospectively from infancy through adulthood
(exceptions: Alastalo et al., 2013a; Alastalo et al., 2013b; Johnson
et al., 2017). In the current study, we tested for sensitive periods of
psychosocial risk – defined as both psychosocial stressors and
socioeconomic risk – that may have the strongest associations
with cardiometabolic outcomes in young adulthood.
The few prospective studies of child maltreatment have supported findings from retrospective studies demonstrating associations between greater psychosocial stress during childhood and
poorer adult cardiometabolic outcomes (Johnson et al., 2017).
Maternal verbally aggressive behavior during infancy has been
associated with higher child blood pressure (BP) at 5–6 years of
age (Smarius, Strieder, Doreleijers, Vrijkotte, & de Rooij, 2018).
Adolescents who had experienced child abuse also showed higher
resting diastolic blood pressure (DBP) and lower systolic blood
pressure (SBP) and DBP reactivity (Gooding, Milliren, Austin,
Sheridan, & McLaughlin, 2015). Some studies have found a
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threshold effect, such that adolescents who experienced four or
more previous adverse experiences demonstrated higher resting
heart rate, waist circumference, and body mass index (BMI)
(Pretty, O’Leary, Cairney, & Wade, 2013). A previous study
with the current cohort demonstrated associations between higher
psychosocial risk during infancy and higher BMI z score at
10 years (Doom et al., 2019b). By adolescence, greater risk for
metabolic syndrome (MetS) and greater cardiometabolic risk
across anthropometric, BP, and serum cardiovascular measures
was observed for adolescents who experienced higher psychosocial risk in infancy (Doom et al., 2019b).
Less research has examined whether particular sensitive periods
are associated with adult cardiovascular risk. A prospective longitudinal birth cohort in New Zealand found that childhood maltreatment between ages 3–11 years was associated with higher levels of
high-sensitivity C-reactive protein (CRP), an inflammatory marker
predictive of CVD, at age 32 years (Danese, Pariante, Caspi, Taylor,
& Poulton, 2007). In a different cohort in the United States, children with documented physical abuse experiences before age
11 years matched with children with no maltreatment experiences
had higher levels of CRP than those without maltreatment 30 years
later (Widom, Czaja, Bentley, & Johnson, 2012). Another study
found that psychosocial stressors before age 12 years were correlated with elevated chronic disease risk in adulthood (Slopen,
Non, Williams, Roberts, & Albert, 2014). These prospective studies
suggest that experiencing high psychosocial risk before age 12 years
may be particularly associated with poor adult cardiometabolic
outcomes. These effects may be partially mediated through early
life programming of the sympathetic nervous system, hypothalamic–pituitary–adrenal (HPA) axis, immune system, and epigenetics, as well as through changes in behavior (Nusslock &
Miller, 2016; Reynolds, 2013; Suglia et al., 2020).
There are multiple developmental periods within the first
12 years of life. Few prospective studies have been able to examine
the relative importance of specific developmental periods. In a
study of adults who were temporarily separated from their parents
as children during World War II, those who were separated during
early childhood (4–7 years old) were more likely to show elevated
BP compared to adults not separated from their parents as children,
with stronger effects for males (Alastalo et al., 2013a). In the same
cohort, male children who were separated at > 7 years of age showed
the highest prevalence of CVD in adulthood compared to adult
males who were not separated as children (Alastalo et al., 2013b).
In a large retrospective study of adults in the United States, heart
disease in adulthood was associated with psychosocial stress experienced during ages 6–10 years and 15–17 years, though the timing
of stress mattered less than repeated exposure to stress (Friedman,
Montez, Sheehan, Guenewald, & Seeman, 2015). Still further,
another study found that low SES in infancy (1–2 years of age)
was predictive of higher inflammatory protein interleukin (IL)-6
during adulthood, even after controlling for adult SES (Carroll,
Cohen, & Marsland, 2011). In the current cohort, lower social capital in infancy, which involved lower parental income and education, not having insurance, and household overcrowding, was
associated with lower high-density lipoprotein (HDL) cholesterol
in adolescence (Madewell, Blanco, Burrows, Lozoff, & Gahagan,
2019). Together, these findings suggest that there may be different
sensitive periods of psychosocial risk for different cardiometabolic
outcomes. However, it may be that psychosocial risk during adulthood is still more predictive of cardiometabolic health than psychosocial risk during childhood (for a review of associations between
adult stress and coronary heart disease, see Wirtz & von Känel,
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2017), emphasizing the need to control for adult psychosocial
risk when measuring adult health outcomes (Pollitt et al., 2007).
There is also evidence that experiencing stressors during multiple
developmental stages, rather than during any particular stage, is
the most predictive of adult heart disease (Friedman et al., 2015).
The repeated exposure to stress may predict chronic responses
and adaptations to stress that may lead to wear and tear on the cardiovascular system over time (McEwen, 1998), which could be
more predictive of cardiovascular risk in adulthood than timing
of stress. We tested the timing versus chronicity question in our
study using repeated, prospective measures of psychosocial risk
from infancy to young adulthood.
The current study examined various psychosocial risks during
infancy, at 5 years, at 10 years, in adolescence, and at young adulthood, to determine the timing of risk that is most closely associated
with young adult cardiometabolic outcomes. The study also examined whether the mean or maximum levels of psychosocial risk
across the four periods from infancy through adolescence were
better predictors of young adult cardiometabolic outcomes than
psychosocial risk at a specific time point. The current study also
examined multiple types of cardiometabolic risk factors, including
BMI, waist circumference, percent body fat (%BF), and BP, rather
than using a single metric of cardiometabolic health. A relatively
large, prospective, longitudinal cohort in Santiago, Chile was used
to test these associations. Based on research findings from this
cohort and others (Carroll et al., 2011; Doom et al., 2019b; East
et al., 2019; Madewell et al., 2019; Smarius et al., 2018), we hypothesized that psychosocial risk during infancy would demonstrate the
strongest association with cardiometabolic outcomes in young
adulthood. Due to evidence that stress before age 12 may be particularly predictive of later cardiometabolic health (Slopen et al., 2014),
we further hypothesized that psychosocial risk at 5 years and
10 years, and mean and maximum of psychosocial risk, would
also be predictive of cardiometabolic outcomes, though associations
would be weaker than with psychosocial risk in infancy.
Method
Analyses used data from the Santiago Longitudinal Study, which
began as an iron deficiency anemia preventive trial in infancy,
with follow-up at 5 years, 10 years, adolescence, and young adulthood (Lozoff et al., 2003). From 1991–1996, 6-month-old infants
and their mothers, who were from working-class neighborhoods,
were recruited from community clinics in Santiago, Chile.
Inclusion criteria for enrollment included birth weight ≥ 3.0 kg, singleton term birth, stable caregiver, vaginal delivery, and residence in
four communities in Santiago. Exclusion criteria included birth
complications, major congenital anomaly, phototherapy, illness,
hospitalization longer than 5 days, iron therapy, another infant less
than 12 months old in the household, infant in day care, or a caregiver who was illiterate or psychotic (self-reported or reported by
family on a recruitment questionnaire) (Lozoff et al., 2003). The
Institutional Review Boards at the participating institutions in the
United States and Chile approved the initial and follow-up studies.
Informed consent was obtained from the parent at each time point
and the target child once they reached young adulthood. Child assent
was obtained at age 10 years and at adolescence.
Study design
Children without iron deficiency anemia at 6 months were randomized to receive high-iron, low-iron, or no iron
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supplementation for 6 months (Lozoff et al., 2003). Children with
iron deficiency anemia and the next nonanemic infant enrolled
were treated with iron instead of entering the preventive trial
and enrolled into additional study components, referred to as
Study 2 (Roncagliolo, Garrido, Walter, Peirano, & Lozoff, 1998).
Infants in both studies were assessed for anemia again at 12
and, for some, at 18 months. Infants with iron deficiency anemia
at 12 or 18 months received iron therapy and completed additional assessments as part of Study 2. All participants in Study
2 reported on psychosocial risk using the same procedures as
participants in the preventive trial. These study design factors
(participating in Study 2, receiving iron in the supplementation
trial) were included as covariates for the analyses.
Due to limited funding at the age 5 years assessment, the
no-added-iron group, the high-iron supplementation group, and
Study 2 participants were invited to participate in a follow-up
assessment where psychosocial risk was assessed (see details of
psychosocial risk measure below). At age 10 years and in adolescence (11–17 years; M = 14.3), all infancy study participants were
invited to participate in an assessment where psychosocial risk
was assessed (Lozoff, Castillo, Clark, & Smith, 2012). In young
adulthood (21–27 years; M = 23.0), all participants were invited
to participate in a cardiometabolic risk assessment. A total of
1040 participants provided cardiometabolic data at the young
adult visit and were included in the current analyses. For the
dual X-ray absorptiometry (DXA) scan to assess body fat, a subset
of the full sample (N = 631) participated in the assessment. This
subset was chosen because they participated in the 5-year assessment and adolescent cardiovascular assessment, which would give
us the most complete longitudinal data for these individuals.
Psychosocial risk
Clinical psychologists interviewed mothers about family-level
psychosocial risk when the infants were 6–12 months old.
Mothers reported on family-level psychosocial risk at 5 years,
10 years, and adolescence as well. Psychosocial risk was operationalized as a composite variable using the top quartile of risk
in seven categories at infancy, 5 years, 10 years, and adolescence:
maternal depressive symptoms (Radloff, 1977, 1991), low support
for child development in the home (Bradley, Corwyn, &
Whiteside-Mansell, 1996; Caldwell & Bradley, 1984), family
stressors ((Bradley et al., 1996; Holmes & Rahe, 1967), father
absence, low family SES (Alvarez, Muzzo, & Ivanovic, 1985),
and years of maternal and paternal education. Quartiles were
defined within each age. Both higher psychosocial stress and
greater socioeconomic risk during childhood have been associated
with more cardiovascular risk factors in adulthood (Dong et al.,
2004; Kittleson et al., 2006). Thus, we chose to include both family SES and maternal and paternal education in the composite to
more fully capture the socioeconomic environment of the family
(Hauser, 1994).
Descriptive statistics were calculated for each of the seven risk
variables to determine quartiles. Maternal depressive symptoms
were assessed using the mother’s report on the Center for
Epidemiological Studies – Depression Scale (Radloff, 1977, 1991)
(CES-D; infancy risk quartile ≥ 22). A trained researcher completed
the Home Observation for Measurement of the Environment
(HOME) Inventory (Caldwell & Bradley, 1984) through home
observation in infancy. The HOME measured home support for
child development, including opportunities for variety in daily
stimulation, provision of play materials, organization of the

https://doi.org/10.1017/S0954579420001248 Published online by Cambridge University Press

J. R. Doom et al.

environment, and the parent’s responsivity and involvement with
the target child (infancy risk quartile < 28). The HOME is well validated and shows sensitivity to variations in families, with validation in Latin America (Bradley et al., 1996; Caldwell & Bradley,
1984). The mother also reported the number of family stressors
using a modified Social Readjustment Rating Scale (Holmes &
Rahe, 1967) (risk quartile > 5). Father absence was reported by
the mother and was assigned a value of 1 if absent and 0 if present.
SES was measured with a modified Graffar index (higher scores
indicate lower SES; infancy risk quartile ≥ 27 (Alvarez et al.,
1985). The Graffar accounts for family-level factors such as number
of people in the home, employment status of the head of household, home ownership, housing construction type and size, availability of running water, ownership of major material goods (e.g.,
home appliances, car), and crowding. The mother reported the
number of years she attended formal education and the years of
education completed by the child’s father (infancy risk quartile
< 9 years). At age 5 years, 10 years, and adolescence, mothers
reported on the same family-level psychosocial risk measures as
in the infancy assessment, with risk quartiles calculated within
each specific age period. At the age 5 years and 10 years assessments, clinical psychologists interviewed mothers to answer
HOME questions. At the adolescent assessment, mothers answered
questions about the HOME directly.
Participants in the risk quartile for each variable were assigned
a value of 1, while those in the other three quartiles were assigned
a value of 0. These values were then summed (within each age
period) to create a risk score that ranged from 0 to 7. For missing
values, scores were prorated with nonmissing items using the
mean across available items. If a participant was missing more
than three risk categories, they were assigned a missing value
for the composite. We have used these composites previously
(Doom, Gahagan, Caballero, Encina, & Lozoff, 2019a; Doom
et al., 2019b). Cutoffs for risk quartiles at age 5 years, 10 years,
and adolescence are reported in the supplemental materials.
In infancy, there was a higher rate of missing data on maternal
depressive symptoms (32%) and father absence (26%) than at
other time points, due to sampling necessitated by budget cuts
(Lozoff et al., 2003). Maternal depressive symptoms and father
absence in infancy were imputed with SPSS 25.0 (10 imputations)
using infancy control variables as well as depressive symptoms
and father absence variables at ages 5 years, 10 years, and at adolescence. These imputed values were used to determine risk quartile for the variables.
This study tested whether the mean or maximum of psychosocial risk from infancy through adolescence was more closely associated with young adult cardiometabolic outcomes than
psychosocial risk at a particular time point. For the mean psychosocial risk, a mean of the psychosocial risk scores at infancy,
5 years, 10 years, and adolescence was calculated. For the maximum psychosocial risk, the highest psychosocial risk score at
any time point from infancy, 5 years, 10 years, and adolescence
was used to assess the highest level of psychosocial risk.
In young adulthood, mothers no longer reported on familylevel psychosocial risk. Instead, young adults themselves reported
on perceived stress using the Perceived Stress Scale (PSS-14)
(Cohen, Kamarck, & Mermelstein, 1983) at a 21 year assessment
preceding the young adult cardiometabolic evaluation. The
21 year visit largely targeted neuromaturation outcomes related
to the aims of the original iron supplementation trial, though
information about young adult psychosocial risk and mental
health was also collected. At 21 years, participants reported on
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their years of education and depressive symptoms using the raw
depression subscale of the Adult Self-Report Scale (Achenbach
& Rescorla, 2003). These variables were entered separately in
the models as covariates.
Young adult anthropometric and cardiometabolic assessment
The following cardiometabolic risk factors were assessed in young
adulthood (median = 22.7 years): BMI, waist circumference, fat
mass index (fat mass/height2), percent fat mass (fat mass/total
body mass), systolic BP (SBP) and diastolic BP (DBP), fasting
plasma glucose, triglycerides (TG), and total and HDL cholesterol.
A research physician used standardized procedures to measure
the height (cm) to the nearest 0.1 cm, using a Holtain stadiometer,
and weight (kg) to the nearest 0.1 kg, using a scale (Seca GmbH &
co. Hamburg, Germany). Waist circumference was measured
with nonelastic flexible tape and recorded to 0.1 cm (Seca 201,
Seca GmbH & co. Hamburg, Germany). Measurements were
taken twice, with a third measurement if the difference between
the first two exceeded 0.3 kg for weight, 0.5 cm for height and
1.0 cm for waist circumference. BMI was calculated as kg/m2.
Total fat mass (TFM) was determined on DXA (apparatus:
Lunar Prodigy Corp., Madison, WI, USA. Software: Lunar iDXA
ENCORE 2011, Version 13.60.033). After 15 min at rest and
before the other physical evaluations, SBP and DBP were measured
three times on the nondominant arm using a standard mercury
sphygmomanometer; the average value of the last two measurements was used for analyses. Fasting serum total glucose
(enzymatic colorimetric test; QCA S.A., Amposta, Spain), total
cholesterol, TG, and HDL-cholesterol (HDL-C) dry analytical
methodology (Vitros®; Ortho Clinical Diagnostics Inc., Raritan,
NJ, USA), were measured after an 8–12 hour overnight fast.
We used the International Diabetes Federation (IDF) criteria
for MetS (Alberti, Zimmet, & Shaw, 2006) to create a continuous
measure of the number of MetS risk components. The following
criteria were used to create five dichotomous variables that were
added to create the number of MetS components variable, which
ranged from 0–5: (a) waist circumference ≥ 90 cm for males
and ≥ 80 cm for females, (b) TG ≥ 150 mg/dL, (c) HDL-cholesterol <40 mg/dL for males and <50 mg/dL for females, (d) SBP
>130 mm Hg or DBP >85 mm Hg, and (e) fasting plasma
glucose ≥100 mg/dL.
Covariates
We considered the following as covariates: age, sex, birthweight,
weight increase from birth to 6 months (in grams), received
iron supplementation in preventive trial (1 = yes, 0 = no), participated in Study 2 (and thus received iron treatment, 1 = yes,
0 = no), daily formula/milk consumption (mean daily formula/
milk consumption [mL/day] between 6 and 12 months, obtained
at weekly home visits), and the young adult’s self-report of
perceived stress, education level, and depressive symptoms at
21 years. We considered family history of CVD based on participant report on whether a parent had any of the following conditions (yes = 1, no = 0): heart disease before age 60, hypertension,
dyslipidemia, or diabetes. The sum of these four variables was
calculated to create a family history of CVD risk score ranging
from 0 to 4. Multiple imputation techniques were used to impute
control variables with missing values (Rubin, 1987) by the study
biostatistician with IVEWARE in SAS (Lozoff et al., 2003;
Raghunathan, Solenberger, & van Hoewyk, 2000).
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Data analytic plan
Principal component analysis to create cardiometabolic
outcome factors
Principal component analysis with SPSS 25.0 was used to
decide how best to calculate composites of cardiometabolic
outcomes, similar to those created using principal component
analysis in a study by Goodman and colleagues (Goodman,
Dolan, Morrison, & Daniels, 2005). For the continuous cardiometabolic outcome variables, individual values were converted
to z scores and then winsorized to 3 SD above or below the
mean to handle outliers. The following cardiometabolic variables were included in the principal component analysis:
BMI, waist circumference, fat mass, fat mass index, percent
fat mass (fat mass/total body mass), SBP, and DBP. This analysis yielded a BP composite (systolic and diastolic; factor loadings ≥ .92; α = .83) and a BMI and waist circumference
composite consisting of those two variables (factor loadings ≥
.98; α = .97). As only a subsample of participants completed
DXA assessments in young adulthood, we considered the
DXA variables as a separate factor composed of fat mass, fat
mass index, and percent fat mass (factor loadings ≥ .96; α
= .98). To account for sex differences in cardiometabolic risk
variables, each of the variables in the composites was standardized within sex such that the three composites were sexadjusted. The mean of the z-scored variables in each of the
components was calculated as the value for that component.
The BMI and waist circumference composite, BP composite,
fat mass composite, and the number of MetS components variables were used as dependent variables in two separate analyses. As the number of MetS components variable included
waist circumference and BP, which were part of the factors
identified in the principal component analysis, it was analyzed
separately from the individual components as a measure of
composite risk.
Sensitive periods model for BMI and waist circumference, BP,
and fat mass
Path analysis with bootstrapping (10,000 iterations) in Mplus 7
(Version 1.4) was conducted to test whether psychosocial risk
at infancy, 5 years, 10 years, or adolescence was most predictive
of cardiometabolic outcomes described above. Figure 1a shows
the main paths tested without covariates displayed. We kept the
dependent composites separate to test whether psychosocial
risk at different time points has unique associations with the
three different types of cardiometabolic outcomes: (a) BMI
and waist circumference composite, (b) BP composite, and
(c) fat mass composite. The across-time measurement of psychosocial risk was included by the direct paths from infancy
to 5 years, 5 years to 10 years, and 10 years to adolescence, as
well as direct paths from each of the four psychosocial risk timing variables to each of the three dependent variables of cardiometabolic risk. Model fit was evaluated with the comparative
fit index (CFI ≥ .90), root mean square error of approximation
(RMSEA < .06), and standardized root mean square residual
(SRMR < .08) (Browne & Cudeck, 1993; Hu & Bentler, 1999;
Kline, 2005). The standard maximum likelihood estimator
was used to estimate the model and to handle missing data.
Covariates on each of the psychosocial risk variables included
sex, birthweight, receiving iron supplementation in infancy,
and participating in Study 2 in infancy. Covariates on each of
the cardiometabolic risk variables included sex, birthweight,
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Figure 1. Path analysis comparing psychosocial risk at infancy, age 5 years, age 10 years, and adolescence predicting cardiometabolic outcomes in young adulthood. Figure 1a includes all the paths tested, and Figure 1b includes the final model. Values presented are standardized coefficients. Solid lines represent significant pathways ( p < .05). *p < 0.05, **p < 0.01, ***p < 0.001.

weight change from 0–6 months (indexing rapid growth),
receiving supplemental iron in infancy, participating in Study
2 in infancy, age, education level, perceived stress, depressive
symptoms, and family cardiovascular risk. To improve model
parsimony, a covariate remained in the model if it demonstrated a direct association with the variable at p < .10. Direct
paths with p values greater than .10 were removed in a stepwise
manner where the variable with the highest p value was
removed first and the model was recomputed until all p values
were less than .10 (final covariates shown in Table 3). After fitting the model for significant covariates, the same process was
conducted for the paths between psychosocial risk and cardiometabolic outcomes. The final paths in the model (minus
covariates) are shown in Figure 1b. A two-sided alpha level of
0.05 was used to determine statistical significance. The
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estimates and 95% confidence intervals (CI) were presented
for all analyses (Table 3).
Sensitive periods model for number of MetS components
The same model as above was tested except with number of MetS
components as the single dependent variable instead of the three
dependent variables of the BMI and waist circumference, BP, and
fat mass composites. The model that was tested is shown in
Figure 2a without covariates. The final paths of the model
(minus covariates) is shown in Figure 2b. The final paths, including covariates, are described in Table 4.
Mean and maximum psychosocial risk
Additional analyses were conducted to determine whether the
mean psychosocial risk across the four time points or the
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Figure 2. Path analysis comparing psychosocial risk at infancy, age 5 years, age 10 years, and adolescence predicting number of metabolic syndrome (MetS) components in young adulthood. Figure 2a includes all the paths tested, and Figure 2b includes the final model. Values presented are standardized coefficients. Solid
lines represent significant pathways ( p < .05). *p < 0.05, **p < 0.01, ***p < 0.001.

maximum psychosocial risk at any of the four time points predicted cardiometabolic outcomes better than risk at any one
time point. Four models were conducted. Two models tested
mean psychosocial risk across the four time points: one model
used the BMI and waist circumference, BP, and fat mass sensitive
periods model, and one model used the number of MetS components sensitive periods model. Two models tested maximum level
of risk across the four time points: one model used the BMI and
waist circumference, BP, and fat mass sensitive periods model,
and one model used the number of MetS components sensitive
periods model. We conducted each model separately as our measures of mean and maximum risk were highly correlated (r = .92).
To test the added predictive value of the mean psychosocial risk,
we computed the final sensitive periods models (Figures 1b and
2b) and added the mean risk score as a predictor of each of the
cardiometabolic risk dependent variables in the two separate
models (first model with BMI and waist circumference, BP, and
fat mass; second model with number of MetS components). We
repeated this method, substituting the maximum psychosocial
risk score variable for the mean psychosocial risk variable in
the two sensitive periods models. Associations of mean and maximum risk with each of the dependent variables were compared to
determine whether either was a better predictor of cardiometabolic outcomes than variables in the model that tested timing of
psychosocial risk.
Results
Descriptive statistics
Mean age of participants at the young adult cardiometabolic
assessment was 23.0 years (range: 21–27; SD = 1.0). Age at the
adolescent assessment also spanned a range from 11–17 years
(M = 14.3, SD = 1.6); the age ranges were relatively smaller at
infancy, 5 years, and 10 years. All participants were Hispanic/
Latinx, and over half (52.1%) were female. Descriptive statistics
for participants in the young adult assessment are included in
Table 1, and a correlation table of study variables is shown in
Table 2.
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Sensitive periods model for BMI and waist circumference, BP,
and fat mass
The final model had good fit to the data (CFI = .94, RMSEA = .05,
SRMR = .04). Greater infant psychosocial risk was associated with
a higher BMI and waist circumference composite (β = 0.08, 95%
CI: 0.03 to 0.13, p = 0.002) and higher body fat (DXA) composite
(β = 0.07, 95% CI: 0.01 to 0.12, p = 0.023) (Table 3). Infant psychosocial risk was not associated with the BP composite, and
this path was excluded from the final model. Figure 3 displays
mean levels of BMI and waist circumference composite and
body fat composite by quartiles of infant psychosocial risk.
Psychosocial risk composites at 5 years, 10 years, and adolescence
were not associated with any of the cardiometabolic risk variables,
and these paths were excluded from the final model. BP was the
only dependent variable not associated with any psychosocial
risk variable. All direct associations, including standardized estimates and 95% CI, are displayed in Table 3.
Sensitive periods model for number of MetS components
The final model fit was satisfactory (CFI = .90, RMSEA = .07,
SRMR = .05). Greater infant psychosocial risk was associated
with a higher number of MetS components (β = 0.07, 95% CI:
0.01 to 0.12, p = 0.020). Psychosocial risk composites at 5 years,
10 years, and adolescence were not associated with the number
of MetS components, and these paths were excluded from the
final model. Figure 3 displays mean levels of number of MetS
components by quartiles of infant psychosocial risk. All direct
associations, including standardized estimates and 95% CI, are
displayed in Table 4.
Mean and maximum psychosocial risk
Mean and maximum psychosocial risk were not associated with
any of the cardiometabolic risk variables, p > .59 (see supplement). The strength of β values between infant psychosocial
risk and each of the three cardiometabolic risk outcomes (number
of MetS components, BMI and waist circumference, and body fat)
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–
−.12**
.16**
.12**
.17***
.11**

–
.93***
.65***
.03

.11**

11.6 (1.2)

.03

69.0 (7.5)

Number of years of education through high school

–

Diastolic blood pressure (mm Hg)

–

110.9 (11.1)

5.

Systolic blood pressure (mm Hg)

6.

9.5 (4.1)

.71***

–

8.

–

35.9 (9.4)
.06

Percent body fat

.09**

26.2 (10.9)

.07*

Fat mass (kg)

.09**

82.5 (11.8)

.92***

26.7 (5.5)

Waist circumference (cm)

7.

BMI

.04

1.2 (1.1)

.53***

Number of MetS components

−.06*

2.2 (1.6)

.50***

2.0 (1.5)

Adolescent psychosocial risk

−.07*

10 years psychosocial risk

.01

1.9 (1.5)

−.20***

5 years psychosocial risk

9.

1.9 (1.3)

.50***

23.0 (1.0)

Infant psychosocial risk

Fat mass index

.07†

–

663 (85.2)

.00

Age at young adult assessment (years)

−.20***

Father present in household in infancy

−.04

–
9.8 (2.8)

−.09**

Father’s education at child’s birth (years)

10.

9.5 (2.7)

.01

26.3 (6.0)

11.

Mother’s age at child’s birth (years)
Mother’s education at child’s birth (years)

.03

498 (47.9)

.02

Male

.06

542 (52.1)

.07*

Female

–

12.

Sex

.64***

Mean (SD)
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.09*
.11**
.12***
13. Depressive symptoms in adulthood

.06

.05
.10**
.06
.08*
12. Perceived stress in adulthood

.00

−.20***

−.01

−.18***
−.16***

−.04
.02
10. Blood pressure composite

−.15***

.09*
9. Fat mass composite

11. Education in adulthood

.02
−.02
.01

.07*

.08*

.04

.06

.03

.02

.09**

.10**

.68***
6. Maximum psychosocial risk

8. BMI and waist circumference Composite

.78***
5. Mean psychosocial risk

7. Number of MetS components

.81***
.79***

.48***
4. Adolescent psychosocial risk

.76***

.84***

–
.62***

–
.49***
3. 10 years psychosocial risk

.63***

.59***
1. Infant psychosocial risk

–
2. 5 years psychosocial risk

–

2.
1.
Variable

Table 2. Correlation table.

Using prospective measures of psychosocial risk from infancy
through adolescence, results from the current study suggest that
psychosocial risk experienced during infancy has the strongest
associations with young adult cardiometabolic outcomes compared to psychosocial risk at 5 years, 10 years, and adolescence.
Specifically, higher infant psychosocial risk was associated with
a higher number of MetS components, a higher BMI and waist
circumference composite, and a higher body fat composite as
measured by DXA. No associations with cardiometabolic outcomes were found for psychosocial risk measured at age 5 years,
age 10 years, or adolescence. Infancy psychosocial risk showed
stronger associations with young adult cardiometabolic risk
than mean risk from infancy through adolescence or maximum
psychosocial risk at any time point.
The finding that infant psychosocial risk was associated with
greater number of MetS components, BMI and waist circumference composite, and body fat composite in young adulthood is
consistent with previous research that demonstrated that low
SES at ages 1–2 years is related to higher IL-6 in adulthood, independent of adult SES (Carroll et al., 2011). Childhood SES was
measured retrospectively in the study by Carroll and colleagues
(2011) by looking at house and vehicle ownership, number of

.58***

3.

Discussion

.85***

remained similar to the models without mean and maximum psychosocial risk.

.86***

4.

Note. Percentages are calculated using participants with non-missing data on the variable.
Values on the psychosocial risk composites ranged from 0–7. MetS= metabolic syndrome

N = 1040. Correlations computed using SPSS v25. †p < 0.10, *p < .05. **p < .01. ***p < .001. MetS = metabolic syndrome.

N (%)

.08*

Measure

13.

Table 1. Descriptive statistics (N = 1040).
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Table 3. Estimates of direct pathways from psychosocial risk at infancy, 5 years,
10 years, and adolescence to cardiometabolic outcomes in young adulthood.
β

95% CI

p
value

Infant psychosocial risk
Randomized to iron
supplementation

0.04, 0.16

0.002

0.10**

0.04, 0.17

0.002

0.60***

0.56, 0.64

<0.001

0.64***

0.60, 0.69

<0.001

10 years psychosocial risk

0.62***

0.58, 0.66

<0.001

Female

0.05†

0.00, 0.10

0.070

Participated in Study 2

0.07*

0.01, 0.12

0.016

5 years psychosocial risk
Infant psychosocial risk

p value

Randomized to iron supplementation

0.10**

0.04, 0.17

0.001

Participated in Study 2

0.10**

0.04, 0.17

0.001

0.60***

0.56, 0.64

<0.001

0.64***

0.60, 0.69

<0.001

10 years psychosocial risk

0.62***

0.58, 0.66

<0.001

Female

0.05†

0.00, 0.10

0.068

Participated in Study 2

0.07*

0.01, 0.12

0.017

Infant psychosocial risk

0.07*

0.01, 0.13

0.020

Female

0.08*

0.02, 0.14

0.011

Age

0.09**

5 years psychosocial risk

10 years psychosocial risk
5 years psychosocial risk

Adolescent psychosocial risk

BMI and waist circumference Composite
Infant psychosocial risk

0.08**

0.03, 0.13

0.002

Birthweight

0.08**

0.03, 0.13

0.003

Age

0.05**

0.02, 0.08

0.002

−0.07, −0.01

0.005

Education level

95% CI

Infant psychosocial risk

10 years psychosocial risk
5 years psychosocial risk

β
Infant psychosocial risk

0.10**

Participated in Study 2

Table 4. Estimates of direct pathways from psychosocial risk at infancy, 5 years,
10 years, and adolescence to number of metabolic syndrome (MetS)
components in young adulthood.

−0.04**

Parent CVD risk factors

0.11***

0.05, 0.18

<0.001

Weight change from 0–6 months

0.06***

0.03, 0.08

<0.001

Depressive symptoms

0.07*

0.01, 0.13

0.022

Infant psychosocial risk

0.07*

0.01, 0.12

0.023

Birthweight

0.06*

0.01, 0.12

0.021

Parent CVD risk factors

0.11***

0.05, 0.18

<0.001

Depressive symptoms

0.07*

0.01, 0.14

0.022

−0.10**

−0.15, −0.04

0.002

0.07, 0.19

<0.001

Body fat composite (DXA)

Adolescent psychosocial risk

Number of MetS components

0.02, 0.15

0.009

Randomized to iron supplementation −0.12**

−0.19, −0.05

0.001

−0.11**

−0.17, −0.04

0.001

Participated in Study 2
Parent CVD risk factors
Perceived stress in young adulthood
Depressive symptoms

0.11***
−0.10*
0.19***

0.05, 0.18

<0.001

−0.18, −0.01

0.025

0.10, 0.28

<0.001

Note. All estimates reported are standardized estimates and 95% confidence intervals (CI)
for each of the direct pathways to number of MetS components. Dependent variables are in
bold with independent variables and associated standardized (β) coefficients.
Note. Covariates were included in the final model if they were associated with the model
variable at p < .10, and psychosocial risk variables were only included as predictors of
number of MetS components if they were associated at p < .10. †p < 0.10, *p < .05. **p < .01.
***p < .001. CVD = cardiovascular disease.

Blood pressure composite
Education level
Parent CVD risk factors

0.13***

Note. All estimates reported are standardized estimates and 95% confidence intervals (CI)
for each of the direct pathways to cardiometabolic outcomes. Dependent variables are in
bold with independent variables and associated standardized (β) coefficients.
Note. Covariates were included in the final model if they were associated with the model
variable at p < .10, and psychosocial risk variables were only included as predictors of
cardiometabolic outcomes if they were associated at p < .10. †p < 0.10, *p < .05. **p < .01.
***p < .001. CVD = cardiovascular disease.

people living in the home and number of bedrooms. In the current study, the SES variable was similar but also included additional items such as parental employment status. We also
considered psychosocial stressors such as family stressors, maternal depressive symptoms, and father absence. Our study and the
Carroll et al. (2011) study suggest that cardiometabolic outcomes
in young adulthood are associated with socioeconomic and psychosocial risk in infancy. Further, this finding extends prior
research from this cohort reporting that psychosocial risk in
infancy is associated with cardiometabolic outcomes in adolescence (Doom et al., 2019b) by demonstrating that psychosocial
risk during infancy is associated cardiometabolic outcomes in
young adulthood as well. These findings support the

https://doi.org/10.1017/S0954579420001248 Published online by Cambridge University Press

developmental origins of disease hypothesis by suggesting that
infancy is an important period during which psychosocial factors
may have implications for future cardiometabolic health.
We did not find associations between psychosocial risk at
age 5, age 10, or adolescence and any of the cardiometabolic
outcomes. This lack of association is inconsistent with previous
research that related childhood stressors to adult BP (Alastalo
et al., 2013a), a predictor of cardiovascular disease. In addition,
our null findings for adolescent psychosocial risk are inconsistent
with a previous study that found that stress experienced at ages 15
to 17 was particularly associated with adult heart disease risk
(Friedman et al., 2015). These discrepancies between studies
might be due to measuring different types of stress. Severe adverse
childhood experiences, such as parent–child separation, were
addressed in previous studies (Alastalo et al., 2013a; Friedman
et al., 2015), whereas we analyzed a broader spectrum of psychosocial risk, which included family stressors, maternal depressive
symptoms, father absence, and low SES. Some studies of the timing of stress were conducted in a sample of adults who were separated from their parents as children during World War II
(Alastalo et al., 2013a; Alastalo et al., 2013b), which is a very different type of stressor than having low SES or high maternal
depressive symptoms. Another factor to consider in evaluating
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findings may be a function of years since psychosocial risk was
assessed rather than there being something unique about the
developmental period of infancy. However, there is precedent
for there being a unique impact of psychosocial risk during
infancy on adult cardiometabolic risk considering evidence of
early life programming of the sympathetic nervous system, HPA
axis, immune system, metabolic system, and behavior (Barker,
2007; Birn, Roeber, & Pollak, 2017; Nusslock & Miller, 2016;
Reynolds, 2013).
Mean and maximum psychosocial risk from infancy through
adolescence were not associated with cardiometabolic outcomes
when added to the model with infant psychosocial risk. These
findings contrast with a previous study demonstrating that
adverse childhood events experienced at multiple time points
were more strongly related to CVD than events experienced at
specific time periods (Friedman et al., 2015). The different findings may relate to different degrees of severity and measures of
psychosocial risk. Severe events were reported retrospectively
(Friedman et al., 2015) compared to a broad psychosocial risk
measure assessed prospectively in our study. Inconsistent results
may also be observed because the biological responses to the
early exposure to psychosocial risk were not considered, which
could shed light on early biological programming.
Chile is an important setting for studies of emerging cardiometabolic risk. The country underwent a rapid economic transition from a low- to a high-income country (Albala, Vio, Kain,
& Uauy, 2002) but with a less dramatic social and educational
transition. Chile now has rates of obesity similar to those in the
United States and other high-income countries. Nearly all
research on sensitive periods of psychosocial risk and cardiometabolic risk have been conducted in countries with high stability in
gross domestic product throughout the lives of participants. The
change in economic context for the families in this study across
children’s development could also have changed the types, chronicity, and severity of stressors they were experiencing. These
findings suggest that the larger sociocultural context, rather
than just the family context, may be an important moderator of
the associations of childhood psychosocial risk with young adult
cardiometabolic outcomes. The results of this study may be particularly applicable to other countries experiencing rapid economic transitions.
Figure 3. Infant psychosocial environment composite risk quartiles by (a) number of
metabolic syndrome (MetS) components, (b) body mass index (BMI) and waist circumference composite, (c) body fat composite, all controlling for sex, young adult
education level, and family cardiovascular risk. Group differences were tested in
SPSS 25 using Bonferroni corrections, †p < .10, *p < .05, **p < .01.

discrepant results across various studies is the age at which cardiometabolic outcomes were assessed. Previous studies found the
association in older adults rather than young adults as in the current study (Felitti et al., 1998; Power, Pereira, & Li, 2015). Our
findings suggest that the sensitive period of infancy is a stronger
predictor of cardiometabolic outcomes in young adulthood than
the other developmental periods. However, it is possible that if
cardiometabolic risk is assessed in this sample in middle or
later adulthood, psychosocial risk at ages 5–10 years might
show associations with cardiometabolic risk at these later time
points. It may be that psychosocial risk requires many years to
be biologically and behaviorally embedded to lead to differences
in cardiometabolic risk. For example, cardiometabolic diseases
such as coronary heart disease and MetS often do not appear
until later in adulthood (Berry et al., 2012). Thus, discrepant
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Study limitations and strengths
Several study limitations should be noted. Some data for a portion
of the sample were missing at age 5 years and for the young adult
DXA assessment due to lack of funding, which may impact the
generalizability of our findings. The restriction of recruitment of
families from low- to middle-income neighborhoods in
Santiago, Chile, also limits the generalization of results to other
socioeconomic contexts. However, it is the individuals from
lower SES backgrounds that are most exposed to stressors from
an early stage. Psychosocial risk measures focused on collection
of parental indicators of risk such as SES, parent education,
home support for child development, and father absence rather
than on the target participants’ perceptions of environmental
risk. We may be missing associations of perceived psychosocial
risk with different measures of cardiometabolic risk, since prospective and retrospective measures of childhood stress appear
to have different associations with psychiatric outcomes
(Newbury et al., 2018). Perceptions of the environment from
the child and biological measures of stress such as disrupted stress
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system or immune system responses could provide a fuller understanding of the environment and stress biology leading to cardiometabolic risk in young adulthood. Risk during the prenatal
period was not assessed in the current study, and the reports of
infant psychosocial risk by mothers in this cohort could reflect
a continuation of psychosocial risk experienced in the prenatal
period. Thus, cohort studies starting in pregnancy and continuing
through adulthood would be well-suited to clarifying effects of
early life exposures. In addition, the young adult measures of
risk did not include the same variables as the measures from
infancy through adolescence. Young adults may not be impacted
in the same way by risk factors reported by their mother. We have
included young adult measures of perceived stress, depressive
symptoms, and education as covariates as these factors may be
related to concurrent psychosocial risk. Unsurprisingly, there
was fairly low variation in levels of psychosocial risk from infancy
through adolescence (see Figures 1b and 2b, and Table 2), though
there was enough variation to detect infancy as a sensitive period
of psychosocial risk to predict young adult cardiometabolic outcomes when controlling for psychosocial risk at different ages.
Strengths of this study include the relatively large sample, good
follow-up rates, the objective measures of multiple cardiometabolic risk factors, and the prospective measurement of psychosocial risk that was assessed consistently from infancy through
young adulthood. We also included multiple covariates in all
analyses which strengthen the interpretation of the model results.
Future directions
The findings of this study suggest several areas for further study.
First, although there is a better understanding of biological and
behavioral alterations following early life stress, few prospective
longitudinal studies are able to target which of these psychosocial
risks may be particularly deleterious for cardiometabolic health.
This future research direction is in line with Dr. Megan
Gunnar’s pioneering research on how psychosocial stress in early
life is embedded biologically and behaviorally to influence health
across development (Gunnar, Doom, & Esposito, 2015). In our
study, psychosocial stress in infancy could have influenced the
development of cardiovascular risk in adulthood through biological
alterations such as changes in the HPA axis, epigenome, cardiovascular system, or immune system, or through behavioral alterations
such as changes in health behaviors (Bunea, Szentágotai-Tătar, &
Miu, 2017; Hughes et al., 2017; Juruena, Agustini, Cleare, &
Young, 2017; Reynolds, 2013; Shonkoff et al., 2012). These alterations may be adaptive for dealing with stress in the short-term
but may have long-term negative effects on cardiovascular health.
By closely tracking psychosocial stress experiences and potential
developmental cascades of biological, psychosocial, and behavioral
adaptations to stress over time, and then understanding which
adaptations have the greatest impact on cardiometabolic health,
we will be able to create interventions that target these mediators
to improve health. However, we must also be cautious of using
interventions to alter biological, psychosocial, or behavioral adaptations to stress if we are not also changing the stressful environment
that produced those adaptations. For example, high levels of psychosocial stress predict greater attention bias to threat (Lakshman
et al., 2020), which over time may lead to poorer cardiovascular
health in a stressful environment. However, an intervention that
reduces attention bias to threat may be harmful in the short
term if an individual does not adequately attend to the many
threats in their environment.
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Second, understanding why psychosocial risk during certain
developmental periods predicts cardiometabolic outcomes during
young adulthood is important for understanding the biological
embedding of early experiences and for creating developmentally
sensitive interventions. The current study suggests that psychosocial risk during infancy is particularly predictive of young adult
cardiometabolic outcomes, which leads to the question of what
may be unique about infancy that it predicts later cardiometabolic
outcomes. Future research should incorporate what is already
known about the rapid stages of biological, brain, socioemotional,
and cognitive development in the first years of life so that we can
better understand why infancy may be a sensitive period during
which psychosocial risk may be especially predictive of later cardiometabolic health. This work on uncovering mechanisms by
which stress influences health during sensitive periods is guided
by Dr. Gunnar’s work with children who have experienced the
extreme psychosocial stress of living in an institution during a
sensitive period of development early in life (Doom, Georgieff,
& Gunnar, 2015; Gunnar, DePasquale, Reid, & Donzella, 2019;
Gunnar & Van Dulmen, 2007). Similar to her work, we need to
explore how psychosocial risk at specific developmental periods
influences potential mediators of later cardiometabolic outcomes
and understand which factors predict who is able to recover from
stress while maintaining positive health.
Third, we need to better understand resilience factors that protect individuals who have experienced high psychosocial risk early
in life from developing poor cardiovascular outcomes. One
important resilience factor – and a target of Dr. Gunnar’s work
on resilience – is high-quality social relationships (Fisher,
Gunnar, Dozier, Bruce, & Pears, 2006; Gunnar, 2017). It will be
important to understand what types of relationships at specific
points in development are most beneficial for reducing poor cardiometabolic outcomes following early stress. Similarly,
individual-level factors such as genetics, coping skills, emotion
regulation, and health behaviors will be important to consider.
In addition, environmental factors, such as neighborhood social
support or availability of high-quality education and support services for families who have experienced high psychosocial risk,
will be important moderators to test. As not all children who
have experienced high psychosocial risk go on to develop CVD,
it will be important to learn who is resilient to these outcomes
to understand whether we can target resilience factors to improve
health.
Finally, there is a need for more randomized controlled trials
(RCTs) to (a) understand causal processes in the association
between psychosocial stress and cardiometabolic outcomes
through RCTs that reduce psychosocial stress, and (b) to test
the effectiveness of psychosocial interventions to improve health.
For example, a RCT of a family- or society-level intervention to
reduce psychosocial and socioeconomic risk in infancy would
shed light on whether psychosocial risk during infancy causes
poor cardiometabolic outcomes. Thus, the RCT would provide
the strongest evidence that interventions reducing psychosocial
risk predict better cardiometabolic outcomes. Similarly, conducting RCTs of interventions that target potential mediators between
psychosocial risk and cardiometabolic health will allow us to test
whether changing the level of the mediator improves adult cardiometabolic health. Research using causal inference models will
also be important for establishing more rigorous evidence of causality. Researchers using RCTs that reduce psychosocial risk or
improve hypothesized mediators or moderators of the association
between psychosocial risk and psychosocial outcomes should

1874

consider collecting data on cardiometabolic outcomes, such as
height, weight, waist circumference, and BP. These cardiometabolic measures are low burden and inexpensive to collect but
will add a great deal to our understanding of psychosocial factors
that positively impact cardiometabolic health across development.
Leveraging existing interventions to enhance our understanding
of how psychosocial risk influences cardiometabolic health is an
important future direction that holds promise to reduce the burden of CVD, which is the number one cause of death in the
United States (Benjamin, Muntner, & Bittencourt, 2019).
Overall, exploring mechanisms, considering sensitive periods
and developmental processes, targeting resilience factors, collecting rigorous experimental evidence, and testing interventions
using RCTs will have important public health implications.

Conclusion
Psychosocial risk experienced during infancy was more strongly
associated with young adult cardiometabolic outcomes than psychosocial risk experienced at other time points. Infant psychosocial risk also predicted young adult cardiometabolic outcomes
better than the mean or maximum level of psychosocial risk
from infancy through adolescence. Our results suggest that reducing psychosocial risk during infancy could be integrated into prevention efforts to improve later cardiometabolic health. Future
directions could further probe the biological and behavioral
mechanisms in the association between infancy psychosocial
risk and adulthood cardiometabolic outcomes by prospectively
measuring psychosocial risk and intensively studying the biological and behavioral alterations at each developmental period
from infancy through adulthood. In addition, future work using
large longitudinal datasets with both biological and behavioral
measurements could be used to uncover additional risk and protective factors across development.
Supplementary Material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0954579420001248
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